TY - JOUR TT - Latest updates on chronic delta hepatitis AU - Yalçın, Kendal AU - Tuncel, Elif Tuğba AU - Gündüz, Feyza PY - 2016 DA - August DO - 10.5472/MMJsi.2901.10 JF - Marmara Medical Journal JO - Marmara Med J PB - Marmara University WT - DergiPark SN - 1019-1941 SP - 50 EP - 54 VL - 29 IS - 2 KW - Hepatit D KW - Tedavi KW - Prognoz N2 - The hepatitis D virus was shown for the first time in 1977 byRizzetto and friends. The HDV genome and the cloning ofsequence were made in 1986. HDV is the first animal virus withcircular RNA genome which is seen only in plant viruses. HDVis an RNA virus with the known smallest viral genome in animalviruses. It is classified as Deltavirus genius depending on the typeof virus by ICTV in 1996. HDV is classified as the sole example ofdelta virus in this genus.Chronic delta hepatitis is the least common form of chronicviral hepatitis due to hepatotropic viruses. In contrast, the virusis highly pathogenic and can cause serious consequences. Today,prevalance of delta hepatitis has been shown to decrease. However,the delta hepatitis continues to be an important health problem insome parts of the world. In our country, especially in Eastern andSoutheastern Anatolia, hepatitis D is a serious and important healthproblem and still maintains its importance as a health problem. InTurkey, still there is a significant number of patients with HDVinfection despite a documented decrease in HDV infection.The recommended treatment for chronic HDV infection in thecurrent guidelines is the treatment with peginterferon alfa givenonce a week for 48 weeks. Treatment is indicated for patients whohas compensated disease with active infection. In patients withadvanced form of disease, the expected benefits of the peginterferonmust be well balanced against the potential side effects and lowresponse rate. An oral antiviral can be recommended in patientswho has high levels of serum HBV DNA. In contrast, the controlof HBV infecion does not seem to change the natural history ofHDV related disease.Keywords: Delta hepatitis, Treatment, Prognosis CR - Rizzetto M. Critical care options. In: Afdhal NH, Zeuzem S CR - editors. Clinical Care Options, Hepatitis, Practice, Hepatitis CR - Delta virus. Last Reviewed: 6/23/14 (What’s New). CR - Taylor JM. Replication of the hepatitis delta virus RNA CR - genome. Adv Virus Res 2009;74:103-21. CR - Greco-Stewart VS, Schissel E, Pelchat M. The hepatitis CR - delta virus RNA genome interacts with the human RNA CR - polymerases I and III. Virology 2009;386:12-5. CR - World Health Organization. Hepatitis B fact sheet 204 CR - (updated July 2013). Available at: http://www.who.int/ CR - mediacentre/factsheets/fs204/en/index.html. Accessed June CR - 2014. CR - Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta CR - virus. Lancet 2011;378:73-85. CR - Rizzetto M, Ciancio A. Epidemiology of hepatitis D. Semin CR - Liver Dis 2012;32:211-9. CR - Farci P. Delta hepatitis: an update. J Hepatol 2003;39(suppl CR - S212-S219. CR - Genné D, Rossi I. Hepatitis delta in Switzerland: a silent CR - epidemic. Swiss Med Wkly 2011 Mar 18. CR - Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB. CR - Italian Hospitals’ Collaborating Group. Evolving clinical CR - landscape of chronic hepatitis B: a multicenter Italian study. J CR - Med Virol 2009;81:1999-2006. CR - Değertekin H, Yalcin K, Yakut M, Yurdaydin C. CR - Seropositivity for delta hepatitis in patients with chronic CR - hepatitis B and liver cirrhosis in Turkey: a meta-analysis. CR - Liver Int 2008;28:494-8. CR - Bahcecioglu IH, Aygun C, Gozel N, Poyrazoglu OK, Bulut Y CR - Yalniz M. Prevalence of hepatitis delta virus (HDV) infection CR - in chronic hepatitis B patients in eastern Turkey: still a serious CR - problem to consider. J Viral Hepat 2011;18:518-24. CR - Degertekin H, Yalcin K, Yakut M. The prevalence of hepatitis CR - delta virus infection in acute and chronic liver diseases in CR - Turkey: An analysis of clinical studies. Turk J Gastroenterol CR - 17:25-34. CR - Yalçın K, Yalçın S, Büyükbayram H, et al. Kronik HDV CR - infeksiyonlu hastalarda serum HBV DNA, HDV RNA CR - düzeyleri ve histolojik bulguların hastalığın klinik evreleriyle ilişkisi: prospektif klinik çalışma. 25. Ulusal Gastroenteroloji CR - Haftası, 2008. CR - Yalçın K, Değertekin H. Etiology and clinical aspects CR - of liver cirrhosis in Diyarbakır. National congress of CR - Gastroenterology, Turkey, 2002. CR - Bonino F, Caporaso N, Dentico P, et al. Familiar clustering CR - and spreading of hepatitis delta virus infection. J Hepatol CR - 1:221-6. CR - Wu JC, Chen CM, Sheen IJ, et al. Evidence of transmission CR - of hepatitis D virus to spouses from sequence analysis of the CR - viral genome. Hepatology 1995;226:1656-60. CR - Rosenblum L, Darrow W, Witte J, et al. Sexual practices CR - in the transmission of hepatitis B virus and prevalence of CR - hepatitis delta virus infection in female prostitutes in the CR - United States. JAMA 1992;267:2477-81. CR - Smedile A, Rizzetto M, Gerin JL. Advances in hepatitis D CR - virus biology and disease. Prog Liver Dis 1994;12:157-75. CR - Dény P. Hepatitis delta virus genetic variability: from CR - genotypes I, II, III to eight major clades? Curr Top Microbiol CR - Immunol 2006;307:151-71. CR - Shakil AO, Hadziyannis S, Hoofnagle JH, et al. Geographic CR - distribution and genetic variability of hepatitis delta virus CR - genotype I. Virology 1997;234:160-7. CR - Alvarado-Mora MV, Romano CM, Gomes-Gouvêa MS CR - Gutierrez MF, Carrilho FJ, Pinho JR. Dynamics of hepatitis CR - D (delta) virus genotype 3 in the Amazon region of South CR - America. Infect Genet Evol 2011;11:1462-8. CR - Rizzetto M. Hepatitis D: thirty years after. J Hepatol CR - 50:1043-50. CR - McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis CR - B virus infection: relation of age to the clinical expression CR - of disease and subsequent development of the carrier state. J CR - Infect Dis 1985;151:599-603. CR - Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. CR - Hepatology 2009;50:661-2. CR - Negro F, Rizzetto M. Diagnosis of hepatitis delta virus CR - infection. J Hepatol 1995;22(1 suppl):136-9. CR - Smedile A, Niro MG, Rizzetto M. Detection of serum HDVRNA CR - by RT-PCR. Methods Mol Med 2004;95:85-93. CR - Le Gal F, Gordien E, Affolabi D, et al. Quantification of CR - hepatitis delta virus RNA in serum by consensus real-time CR - PCR indicates different patterns of virological response to CR - interferon therapy in chronically infected patients. J Clin CR - Microbiol 2005;43:2363-9. CR - Schaper M, Rodriguez-Frias F, Jardi R, et al. Quantitative CR - longitudinal evaluations of hepatitis delta virus RNA and CR - hepatitis B virus DNA shows a dynamic, complex replicative CR - profile in chronic hepatitis B and D. J Hepatol 2010;52:658- CR - Mederacke I, Bremer B, Heidrich B, et al. Establishment of a CR - novel quantitative hepatitis D virus (HDV) RNA assay using CR - the Cobas TaqMan platform to study HDV RNA kinetics. J CR - Clin Microbiol. 2010;48:2022-9. CR - Pascarella S, Negro F. Hepatitis D virus: an update. Liver Int CR - 31:7-21. CR - Fattovich G, Giustina G, Christensen E, et al. Influence of CR - hepatitis delta virus infection on morbidity and mortality CR - in compensated cirrhosis type B. The European Concerted CR - Action on Viral Hepatitis (Eurohep). Gut 2000;46:420-6. CR - Cross TJ, Rizzi P, Horner M, et al. The increasing prevalence CR - of hepatitis delta virus (HDV) infection in South London. J CR - Med Virol 2008;80:277-82. CR - Ji J, Sundquist K, Sundquist J. A population-based study of CR - hepatitis D virus as potential risk factor for hepatocellular CR - carcinoma. J Natl Cancer Inst 2012;104:790-2. CR - Niro GA, Rosina F, Rizzetto M. Treatment of hepatitis D. J CR - Viral Hepat 2005;12:2-9. CR - Gunsar F, Akarca US, Ersoz G, et al. Two-year interferon CR - therapy with or without ribavirin in chronic delta hepatitis. CR - Antivir Ther 2005;10:721-6. CR - Calle Serrano B, Manns MP, Wedemeyer H. Hepatitis delta CR - and HIV infection. Semin Liver Dis 2012;32:120-9. CR - Castelnau C, Le Gal F, Ripault MP, et al. Efficacy of CR - peginterferon alpha-2b in chronic hepatitis delta: relevance CR - of quantitative RT-PCR for follow-up. Hepatology CR - 44:728-35. CR - Mederacke I, Yurdaydin C, Dalekos GN, et al. Anti-HDV CR - immunoglobulin M testing in hepatitis delta revisited CR - correlations with disease activity and response to pegylated CR - interferon-α2a treatment. Antivir Ther 2012;17:305-12. CR - Di Martino V, Thevenot T, Colin JF, et al. Influence of CR - HIV infection on the response to interferon therapy and the CR - long-term outcome of chronic hepatitis B. Gastroenterology CR - 123:1812-22. CR - Soriano V, Puoti M, Peters M, et al. Care of HIV patients with CR - chronic hepatitis B: updated recommendations from the HIVHepatitis CR - B Virus International Panel. AIDS 2008;22:1399- CR - Samuel D, Zignego AL, Reynes M, et al. Long-term CR - clinical and virological outcome after liver transplantation CR - for cirrhosis caused by chronic delta hepatitis. Hepatology CR - 21:333-9. CR - Burra P, Germani G, Adam R, et al. Liver transplantation CR - for HBV-related cirrhosis in Europe: an ELTR study on CR - evolution and outcomes. J Hepatol 2013;58:287-96. CR - Lamers MH, Kirgiz ÖÖ, Heidrich B, Wedemeyer H, Drenth CR - JP. Interferon-α for patients with chronic hepatitis delta: a CR - systematic review of randomized clinical trials. Antivir Ther CR - 17:1029-37. CR - Bordier BB, Ohkanda J, Liu P, et al. In vivo antiviral efficacy CR - of prenylation inhibitors against hepatitis delta virus. Clin CR - Invest 2003;112:407-14. CR - Chang J, Taylor JM. Susceptibility of human hepatitis CR - delta virus RNAs to small interfering RNA action. J Virol CR - 77:9728-31. CR - Fiedler M, Kosinska A, Schumann A, et al. Prime/boost CR - immunization with DNA and adenoviral vectors protects CR - from hepatitis D virus (HDV) infection after simultaneous CR - infection with HDV and woodchuck hepatitis virus. J Virol CR - 87:7708-16. UR - https://doi.org/10.5472/MMJsi.2901.10 L1 - https://dergipark.org.tr/en/download/article-file/221753 ER -